US Patent Issued to BETTERLIFE PHARMA on June 17 for "LSD derivatives, synthesis and method for treatment of diseases and disorders" (Canadian, American Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,051, issued on June 17, was assigned to BETTERLIFE PHARMA INC. (Vancouver, Canada).

"LSD derivatives, synthesis and method for treatment of diseases and disorders" was invented by Hooshmand Sheshbaradaran (Toronto), Scott Rudge (Boulder, Colo.), Abdi Ghaffari (Kingston, Canada), Stefan Soderman (Drayton, Canada) and Petar Duspara (Mississauga, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "LSD derivative compounds and polymorphs thereof, methods for their synthesis, compositions and treatment of diseases and disorders are described herein, the compounds having the structure of Formula I:including pharmaceutically acceptable salts, hydrates, s...